|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 157.77 USD | +1.83% |
|
+13.47% | +50.73% |
| 08-04 | Palvella Therapeutics, Inc., Q2 2026 Earnings Call, Aug 04, 2026 | |
| 08-04 | Palvella Therapeutics Q2 Net Loss Widens | MT |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 172.83 | 208.27 | 213.73 |
| Spread/Res. | -8.71% | -24.25% | -26.18% |
| Spread/Supp. | +13.47% | +33.18% | +45.18% |
| Support | 139.04 | 118.46 | 108.67 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- PVLA Stock
- Charts Palvella Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
